Dr. Sahdeo Prasad has joined our department Biotechnology and Immunotherapeutics, Texas Tech University as a Research Instructor. Dr. Prasad has obtained his Ph.D. (Biotechnology), CSJM University, Kanpur, India and Indian Institute of Toxicology Research (CSIR), Lucknow, India collaboratively. During doctoral research program, he extensively worked on signal transduction pathways in both in vivo and in vitro tumor models. Dr. Prasad received National Eligibility Test (CSIR - UGC-NET), Graduate Aptitude Test in Engineering (GATE) and Indian Council of Medical Research Junior Research Fellowship award (ICMR-JRF) by Govt. of India during his Master program. Before joining our department, he worked as Post - Doctoral Fellow in Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center and in Department of Pharmacology, University of Pittsburgh, PA. His expertise is in the area of molecular biology with particular reference to molecular mechanisms of signal transduction in tumor cells. Dr. Prasad has discovered a number of phytochemicals with chemo-preventive effects against a variety of cancers and their mechanism of action. Besides these, Dr. Prasad’s work is also focused on the effect of natural compounds on death receptor pathways, bone loss and chemosensitization of tumor cells. The current research focus of Dr. Prasad is identification of novel drug as a chemo-preventive and chemotherapeutic agents that could suppress the activation of transcription factors, kinases and oncogenes. His research area also include to explore the efficacy of novel drugs in vivo in preclinical experiments with suitable animal models and to verify changes in surrogate biomarkers. He has numerous National and International publications, abstracts Indexed in International conferences. He is also an editorial board member of various reputed journals and member of various scientific societies.

Igor Grachev, M.D., Ph.D. is a Neurologist, Psychiatrist, Neuroscientist, Drug Developer, Translational Medicine/POC, Clinical Development, Medical Affairs and Imaging expert with over 20 years of extensive Pharma industry, academic and CRO biomedical research experience who has had roles of increasing responsibility and scope at MGH/Harvard Medical School, SUNY Upstate Medical University, Schering-Plough, Sanofi-Aventis, Merck, BioClinica, Merck Sharp & Dohme Corp, GE Healthcare, and Novartis Consumer Health. All his industry roles have involved the application of imaging, biomarkers and clinical neuroscience to drug development. Dr. Grachev is a member of the Coalition Against Major Diseases (CAMD), QIBA DCE-MRI, FDG- and amyloid-PET steering committees of RSNA, ADNI and ADNI2, Society of Nuclear Medicine, International Society to Advance Alzheimer Research and Treatment and has written and co-authored over 100 clinical research scientific publications including chapters on imaging biomarkers/technologies in three books “Methods in Pain Research (CRC Press),” “Complex Regional Pain Syndrome (IASP Press)” and “Imaging in CNS Drug Development (Springer Science, NY),” and served as a Chair of Industry Scientific Advisory Board for Parkinson’s Progression Markers Initiative, Michael J. Fox Foundation. Research interest: Neurobiology of Neurodegenerative disorders (Parkinson’s disease, Alzheimer’s disease, Multiple Sclerosis), Insomnia (incl. PSG), OCD, Depression, Anxiety, Schizophrenia, ADHD, Migraine, Acute & Chronic Pain, Stroke and other indications. Expert in clinical biomarkers and the following Imaging modalities: PET, SPECT, and MRI (Gd-MRI, vMRI, fMRI, MRS, DCE-MRI).

Dr. Martin Steinhoff received his double PhD ‘s from University of Marburg, Germany and UCSF, USA respectively. He is currently Chairman for Department of Dermatology and Venerology, Hamad Medical Corporation, Medical School, Qatar University &Weill Cornell University Doha, Qatar. He also, worked as Chairman, Director at Department of Dermatology, UCD Charles Institute of Dermatology, University College Dublin, Ireland. He had received number of honors and awards like Allergy Award [1996], Research Award Roche-Posay [2000], Oskar-Gans main scientific award, German Society of Dermatology [2001], Research Award of the Rosacea-Foundation, USA [2003], Victor von Bruhns Research Award of the Society for Wound Healing, Weimar, Germany [2004], Honor award: "Berlin Society of Dermatology" Berlin, Germany [2006], Research Award from National Rosacea Society (NRS), USA [2009, 2011], SFI-Pfizer Innovation Research Award from Minister of Health (D. English), Ireland [2016] and many more. His clinical research interests include Complex general dermatology, Atopic dermatitis, Rosacea/Acne, Melanoma, Wound healing, sclerotherapy. Dermatology Consultant for other Departments: Internal medicine, transplantation, cancer clinic, surgery. He has given more than 200 national/international invited lectures including Natl Acac Sciences New York. Research Interest: Allergic Diseases, Protease Inhibitors, Atopic eczema/dermatitis, Rosacea, Psoriasis, Cell Signaling Pathways, Immunity, Chronic Inflammation, Comparative Genomics

Dr. Kamil Zelenak was a Medical doctor from University of P.J. Šafárik, Košice.He was a Interventional radiologist from Institute of Postgraduate Medical Education, Prague, Czech Republic. He was also Associate. Professor. from Palacký University Olomouc, Czech republic.He was a member of European Society of Radiology.

Doctor Alexandre received his Degree in Medicine cum Laude at the Campus Bio-Medico University of Rome in 2008. He spent three months as medical elective student in the department of neurosurgery at the West London Neurosciences Centre, Hammersmith Hospital – Imperial College, and in the department of neurosurgery at the Royal London Hospital, The Barts and the London. He became specialist in radiology cum Laude at the Catholic University of Rome in 2014. He did a two-years fellowship in interventional neuroradiology at the NEURI, Brain Vascular Center, Beaujon Hospital – Bicêtre Hospital, in Paris. Since the end of 2015 he works as a neuroradiologist and interventional neuroradiologist in the department of radiology and neuroradiology at the Fondazione Policlinico Universitario A.Gemelli, in Rome. He currently serves as reviewer for the journals: Neurosurgery, World Neurosurgery, Annals of Neurodegenerative Disorders and he is part of the Editorial Board member for EC Neurology journal.